Myeloperoxidase and its products in synovial fluid of patients with treated or untreated rheumatoid arthritis

Free Radical Research

Volumn 48, Issue 4, 2014, Pages 461-465

  Nzeusseu Toukap, A ^a   Delporte, C ^b   Noyon, C ^b   Franck, T ^c   Rousseau, A ^b   Serteyn, D ^c   Raes, M ^d   Vanhaeverbeek, M ^b   Moguilevsky, N ^e   Neve J ^b   Vanhamme, L ^b   Durez, P ^a   Van Antwerpen, P ^b   Zouaoui Boudjeltia, K ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d University of Namur   (Belgium)

^e UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Chloro tyrosine; Homocitrulline; Interleukine 8; Myeloperoxidase; Synovial fluid

Indexed keywords

BIOLOGICAL FACTOR; BIOLOGICAL PRODUCT; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HOMOCITRULLINE; INTERLEUKIN 18; INTERLEUKIN 8; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; CYTOKINE; PEROXIDASE;

ARTICLE; ARTICULAR CARTILAGE; DAS28; ENZYME ACTIVITY; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; FEMALE; IMMUNOLOGY; MALE; METABOLISM;

ARTHRITIS, RHEUMATOID; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-8; MALE; PEROXIDASE; SYNOVIAL FLUID;

EID: 84895750015     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.886327     Document Type: Article

References (18)

1. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008; 58: 15-25.
2. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008; 58: 26-35.
3. Wruck CJ, Fragoulis A, Gurzynski A, Brandenburg LO, Kan YW, Chan K, et al. Role of oxidative stress in rheumatoid arthritis: Insights from the Nrf2-knockout mice. Ann Rheum Dis 2011; 70: 844-850.
4. Steinbeck MJ, Nesti LJ, Sharkey PF, Parvizi J. Myeloperoxidase and chlorinated peptides in osteoarthritis: Potential biomarkers of the disease. J Orthop Res 2007; 25: 1128-1135.
5. Mydel P, Wang Z, Brisslert M, Hellvard A, Dahlberg LE, Hazen SL, Bokarewa M. Carbamylation-dependent activation of T cells: A novel mechanism in the pathogenesis of autoimmune arthritis. J Immunol 2010; 184: 6882-6890.
6. Fernandes RM, da Silva NP, Sato EI. Increased myeloperoxidase plasma levels in rheumatoid arthritis. Rheumatol Int 2012; 32: 1605-1609.
7. Stamp LK, Khalilova I, Tarr JM, Senthilmohan R, Turner R, Haigh RC, et al. Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology 2012; 51: 1796-1803.
8. Dai SM, Shan ZZ, Xu H, Nishioka K. Cellular targets of interleukin-18 in rheumatoid arthritis. Ann Rheum Dis 2007; 66: 1411-1418.
9. Hammond ME, Lapointe GR, Feucht PH, Hilt S, Gallegos CA, Gordon CA, et al. IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors. J Immunol 1995; 155: 1428-1433.
10. Park HJ, Kim SS, Lee SY, Park NH, Park JY, Choi YJ, Jeon HJ. A practical MRI grading system for osteoarthritis of the knee: Association with Kellgren-Lawrence radiographic scores. Eur J Radiol 2013; 82: 112-117.
11. Wells G, Becker JC, Teng J, Dougados M, SchiffM, Smolen J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 2009; 68: 954-960.
12. Franck T, Kohnen S, Boudjeltia KZ, Van Antwerpen P, Bosseloir A, Niesten A, et al. A new easy method for specific measurement of active myeloperoxidase in human biological fl uids and tissue extracts. Talanta 2009; 80: 723-729.
13. Delporte C, Franck T, Noyon C, Dufour D, Rousseau A, Madhoun P, et al. Simultaneous measurement of proteinbound 3-chlorotyrosine and homocitrulline by LC-MS/MS after hydrolysis assisted by microwave: Application to the study of myeloperoxidase activity during hemodialysis. Talanta 2012; 99: 603-609.
14. Attur MG, Dave M, Akamatsu M, Katoh M, Amin AR. Osteoarthritis or osteoarthrosis: The definition of infl ammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 2002; 10: 1-4.
15. Sokolov AV, Ageeva KV, Pulina MO, Cherkalina OS, Samygina VR, Vlasova II, et al. Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other. Free Radic Res 2008; 42: 989-998.
16. Van Antwerpen P, Slomianny MC, Boudjeltia KZ, Delporte C, Faid V, Calay D, et al. Glycosylation pattern of mature dimeric leukocyte and recombinant monomeric myeloperoxidase: Glycosylation is required for optimal enzymatic activity. J Biol Chem 2010; 285: 16351-16359.
17. Cross AS, Wright DG. Mobilization of sialidase from intracellular stores to the surface of human neutrophils and its role in stimulated adhesion responses of these cells. J Clin Invest 1991; 88: 2067-2076.
18. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, et al. Protein carbamylation links infl ammation, smoking, uremia and atherogenesis. Nat Med 2007; 13: 1176-1184.